Search
for
Sort by
Research 61–90 of 1000+
- Effects of aromatase inhibitors on human osteoblast and osteoblast-like cells: A possible androgenic bone protective effects induced by exemestane
- Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
- An overview on 5α-reductase inhibitors
- The enzyme and inhibitors of 4-ene-3-oxosteroid 5α-oxidoreductase
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Enzyme Inhibitors from Gorgonians and Soft Corals
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Ritlecitinib: First Approval
- Chapter 14 Principles of drug metabolism
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- Phospholipase A2 Is Required for PIN-FORMED Protein Trafficking to the Plasma Membrane in the<i>Arabidopsis</i>Root
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Treatment options for alopecia: an update, looking to the future
- Hidradenitis Suppurativa
- In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5α-reductase inhibitors
- NON-PSORALEN TREATMENT OF VITILIGO. PART II. LESS COMMONLY USED AND EXPERIMENTAL THERAPIES
- Hair and nail involvement in lupus erythematosus
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- Pharmacodynamic modeling of finasteride, a 5 alpha-reductase inhibitor.
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Dermatologic Adverse Events from Cancer Treatments
- Management of Toxicities of Targeted Therapies
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors